We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

162 hedge funds and large institutions have $873M invested in Momenta Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

368% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $329K

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

31% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 49

1% more funds holding

Funds holding: 160 → 162 (+2)

9% less capital invested

Capital invested by funds: $962M → $873M (-$89.3M)

Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
64
Reduced
49
Closed
18
Calls
$1.54M
Puts
$329K
Net Calls
+$1.21M
Net Calls Change
-$493K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$137M
2
NI
Numeric Investors
Massachusetts
+$14.4M
3
State Street
State Street
Massachusetts
+$9.05M
4
FCMI
Foresite Capital Management III
California
+$6.74M
5
EDRH
Edmond de Rothschild Holding
Switzerland
+$6.58M

Top Sellers

Rank Fund Capital Flow
1
DCM
Discovery Capital Management
Connecticut
-$22.7M
2
Millennium Management
Millennium Management
New York
-$17.6M
3
O
OrbiMed
New York
-$13.2M
4
SC
Samlyn Capital
New York
-$3.97M
5
SAM
Senzar Asset Management
New York
-$3.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
51
VOYA Investment Management
Georgia
$1.64M +$1.5M +96,056 +356%
Millennium Management
52
Millennium Management
New York
$1.64M -$17.6M -1,121,716 -90%
CS
53
Credit Suisse
Switzerland
$1.62M +$684K +43,685 +56%
AMI
54
Amica Mutual Insurance
Rhode Island
$1.59M – – –
NFA
55
Nationwide Fund Advisors
Ohio
$1.5M +$1.13M +72,361 +179%
Legal & General Group
56
Legal & General Group
United Kingdom
$1.5M +$40.8K +2,603 +2%
Swiss National Bank
57
Swiss National Bank
Switzerland
$1.47M – – –
Prudential Financial
58
Prudential Financial
New Jersey
$1.46M +$16.6K +1,060 +1%
Arrowstreet Capital
59
Arrowstreet Capital
Massachusetts
$1.43M +$1.68M +107,022 New
MCM
60
Matarin Capital Management
New York
$1.39M +$1.63M +104,375 New
MC
61
Marcus Capital
Illinois
$1.32M +$1.55M +98,800 New
WT
62
Whittier Trust
California
$1.29M +$73K +4,658 +5%
New York State Teachers Retirement System (NYSTRS)
63
New York State Teachers Retirement System (NYSTRS)
New York
$1.25M – – –
AllianceBernstein
64
AllianceBernstein
Tennessee
$1.22M -$89.3K -5,700 -6%
Macquarie Group
65
Macquarie Group
Australia
$1.2M +$157K +10,000 +13%
Jacobs Levy Equity Management
66
Jacobs Levy Equity Management
New Jersey
$1.19M +$1.39M +89,031 New
Canada Life
67
Canada Life
Manitoba, Canada
$1.18M +$77.3K +4,936 +6%
TC
68
TFS Capital
Pennsylvania
$1.17M +$1.37M +87,377 New
PNC Financial Services Group
69
PNC Financial Services Group
Pennsylvania
$1.02M -$594K -37,894 -33%
Comerica Bank
70
Comerica Bank
Texas
$1.01M +$57.2K +3,652 +5%
First Trust Advisors
71
First Trust Advisors
Illinois
$1M +$1.18M +75,093 New
VEA
72
Virtus ETF Advisers
New York
$970K +$109K +6,987 +11%
APFBOT
73
Amica Pension Fund Board of Trustees
Rhode Island
$966K – – –
OAM
74
Oxford Asset Management
United Kingdom
$887K +$619K +39,511 +147%
PPA
75
Parametric Portfolio Associates
Washington
$868K -$19.2K -1,227 -2%
1 2
3
4 5

MNTA Hedge Fund Activity: Q1 2017 in Review

162 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q1 2017, worth a combined $873M — down 9.3% from $962M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MNTA positions and 18 closed out — a net gain of 7 holders — while 64 added to existing stakes and 49 trimmed.

The largest buyer was BlackRock, adding an estimated $137M. The largest seller was Discovery Capital Management, cutting an estimated $22.7M.

  • 162 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q1 2017, up from 160 in Q4 2016.
  • Funds reported $873M of Momenta Pharmaceuticals, Inc. stock for Q1 2017, down 9.3% quarter-over-quarter.
  • 25 funds opened new Momenta Pharmaceuticals, Inc. positions in Q1 2017 and 18 closed out, a net change of +7 holders.
  • The largest Momenta Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $137M added.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q1 2017 was Discovery Capital Management, an estimated $22.7M sold.

Based on aggregated 13F filings for Q1 2017.